L-carnitine.
Publication
, Journal Article
Published in: Med Lett Drugs Ther
November 22, 2004
Although advertised on the Internet for weight loss, prevention of aging and enhancement of athletic and sexual performance, levocarnitine has only one well-established indication, and that is for treatment of carnitine deficiency. In clinical trials, the drug also seems to have had modest effects in some other conditions, particularly intermittent claudication and recovery after myocardial infarction, but more studies are needed.
Duke Scholars
Published In
Med Lett Drugs Ther
ISSN
0025-732X
Publication Date
November 22, 2004
Volume
46
Issue
1196
Start / End Page
95 / 96
Location
United States
Related Subject Headings
- Vomiting
- Randomized Controlled Trials as Topic
- Pharmacology & Pharmacy
- Nausea
- Intermittent Claudication
- Humans
- Fatigue Syndrome, Chronic
- Double-Blind Method
- Dietary Supplements
- Deficiency Diseases
Citation
APA
Chicago
ICMJE
MLA
NLM
L-carnitine. (2004). Med Lett Drugs Ther, 46(1196), 95–96.
“L-carnitine.” Med Lett Drugs Ther 46, no. 1196 (November 22, 2004): 95–96.
L-carnitine. Med Lett Drugs Ther. 2004 Nov 22;46(1196):95–6.
“L-carnitine.” Med Lett Drugs Ther, vol. 46, no. 1196, Nov. 2004, pp. 95–96.
L-carnitine. Med Lett Drugs Ther. 2004 Nov 22;46(1196):95–96.
Published In
Med Lett Drugs Ther
ISSN
0025-732X
Publication Date
November 22, 2004
Volume
46
Issue
1196
Start / End Page
95 / 96
Location
United States
Related Subject Headings
- Vomiting
- Randomized Controlled Trials as Topic
- Pharmacology & Pharmacy
- Nausea
- Intermittent Claudication
- Humans
- Fatigue Syndrome, Chronic
- Double-Blind Method
- Dietary Supplements
- Deficiency Diseases